2021 Radiopharmaceutical ọgwụgwọ na Benign na Ọrịa Ọrịa: Radiotheragnostic Practicum
GA-ECHI ỌZỌ VIA LIFETIME DOWNLOAD LINK (Ọsọ ọsọ) MGBE ịkwụ ụgwọ
Ọrụ agụmakwụkwọ a na-aga n'ihu na-enyocha omume kachasị mma na ngalaba rediotheragnostics na-eto eto (aka theranostics ma ọ bụ theragnostics) maka ọrịa na-adịghị mma na ajọ ọrịa, na-amalite site na ntọala ma na-agbakwunye ịgụnye usoro ọgwụgwọ dị elu. Nyochaa nke usoro ọgwụgwọ emebere ka akụkọ ihe mere eme nke kachasị rụọ ọrụ nke ọma yana usoro eji arụ ọrụ ọhụụ ewepụtara gụnyere. Onye ọkachamara ọkachamara na-atụle njikarịcha nke usoro rediotheragnostic maka iji ihe kachasị mma nke usoro ọgwụgwọ dị iche iche na usoro nlekọta ahụike nke oge a, ma usoro agụmakwụkwọ na nke onwe.
Target-ege Ntị
Ezubere nzukọ a maka ndị dibịa ọgwụ nuklia, ndị na-ahụ maka redio, ndị ọkà mmụta banyere oncologists, ndị ọkachamara n'ihe gbasara ahụike, na ndị na-ahụ maka ọgwụ.
Ihe mgbaru ọsọ
Mgbe emechara ọrụ CME a, ndị debanyere aha ga-enwe ike:
- Ihe dị iche n'etiti usoro rediotheragnostic na echiche ndị ọzọ dị iche iche na-eduzi nnyefe ọgwụgwọ nke radieshon na anụ ahụ ezubere iche na ebumnuche iji melite nsonaazụ ahụike.
- Usoro ọgwụgwọ kacha mma na-abịakwute hyperthyroidism na ọrịa ndị ọzọ na-arịa ọrịa thyroid, dabere na ihe akaebe na / ma ọ bụ ikpe ahụike dị mma.
- Usoro ọgwụgwọ kacha mma na-abịaru nso ka carcinoma thyroid dị iche, dabere na ihe akaebe na / ma ọ bụ ikpe ahụike dị mma.
- Ngwa kachasị nke Y-90 Ibritumomab Tiuxetan maka ọgwụgwọ nke lymphoma.
- Ngwa kachasị mma nke I-131 Iobenguane iji chọpụta ihe nyocha na ọgwụgwọ Pheochromocytoma na Paraganglioma.
- Ngwa kachasị nke Y-90 Resin na Glass Microspheres maka ọgwụgwọ redio nke ọrịa cancer imeju.
- Ngwa kachasị mma nke Ga-68 Dotatate Imaging na Lu-177 Dotatate ọgwụgwọ nke etuto neuroendocrine.
- Thezọ kachasị mma iji chọpụta ihe nyocha nke nlọghachi azụ na ọrịa cancer prostate metastatic.
- Thezọ kachasị mma maka ọgwụgwọ nke ọrịa metastatic skeletal na-eji ọtụtụ Ọkpụkpụ-achọ radiopharmaceuticals.
- Ezigbo ihe atụ maka nyocha nke edepụtara edeghị ọrịa kansa maka ọnwụnwa sitere na radiotheragnostics.
- approzọ kacha mma iji wuo omume rediotheragnostic na ụlọ akwụkwọ agụmakwụkwọ.
- approzọ kacha mma iji wulite omume rediotheragnostic na ntọala ntọala nkeonwe.
Isiokwu na ndị na-ekwu okwu:
Akụkọ & Omume nke ọgwụgwọ Radioiodine na Hyperthyroidism
Emeka Nweke, MD, FACNM, FSNMMI, CCD
Isi nke usoro ọgwụgwọ ezubere iche - Ihe Mmụta Mụtara
Terence Z. Wong, MD, Ph.D.
Ọgwụ Radioiodine: Ọnọdụ Thyroid Na-adịghị Ahụkarị
Emeka Nweke, MD, FACNM, FSNMMI, CCD
I-131 Iobenguane Imaging & ọgwụgwọ maka Pheochromocytoma / Paraganglioma
Erik S. Mittra MD, Ph.D.
Radioiodine na Thyroid Cancer - Ntọala
Emeka Nweke, MD, FACNM, FSNMMI, CCD
Radioiodine na Ọrịa Cancer Thyroid - Ọganihu
Emeka Nweke, MD, FACNM, FSNMMI, CCD
Ngwurugwu Radioembolization na Y-90 Resin na Glass Microspheres
Terence Z. Wong, MD, Ph.D.
Ga-68 / Lu-177 Dotatate Imaging / Agwọ nke Neuroendocrine Tumors
Erik S. Mittra MD, Ph.D.
Diagnostic Imaging nke Ntighari na Metastatic Prostate Cancer
Samuel Mehr, MD
Agwọ maka Ọrịa Na-ahụ Maka Ọrịa Na-ahụ Maka Ọrịa Na-ahụ Maka Ọrịa Na-ahụ Maka Ọrịa
Terence Z. Wong, MD, Ph.D.
Radiotheragnostics na Ọrịa Cancer
Terence Z. Wong, MD, Ph.D.
Ọnwụnwa dị mkpa na USA maka Radiotheragnostics na-abịa
Erik S. Mittra MD, Ph.D.
Ohere maka nnabata Somatostatin na-ezubere iche na Avid Cancers
Samuel Mehr, MD
Iwulite usoro ọgwụgwọ ọgwụ Nuclear na Omume Ọmụmụ
Erik S. Mittra MD, Ph.D.
Iwulite Usoro Ngwuputa Ngwurugwu Nuclear na Omume Onwe
Samuel Mehr, MD